maximizing Oncology Research with Integrated KRAS Assay products and services and RAS Assays
In the rapidly evolving field of oncology analysis, accurate and successful mutation screening is crucial for developing focused therapies. The KRAS Services Platform plays a pivotal job in this landscape by providing detailed alternatives for KRAS mutation profiling and Assessment. KRAS mutations, found in roughly ninety five% of RAS-relevant onco